Research programme: wnt signalling pathway modulators - Renovo

Drug Profile

Research programme: wnt signalling pathway modulators - Renovo

Alternative Names: RN 1005

Latest Information Update: 08 Jun 2011

Price : $50

At a glance

  • Originator Renovo
  • Class Wnt proteins
  • Mechanism of Action Wnt signalling pathway modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Scars

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top